OverviewSuggest Edit

R1 RCM (formerly Accretive Health) is a provider of technology-enabled revenue cycle management (RCM) services. It aims to transform and solve revenue cycle performance challenges across hospitals, health systems, and physician groups. The company also provides modular services comprising physician advisory, patient experience, revenue integrity, and other services.

TypePublic
Founded2003
HQChicago, IL, US
Websiter1rcm.com
Employee Ratings2.5

Latest Updates

Employees (est.) (Feb 2020)19,000(+16%)
Job Openings658
Revenue (FY, 2020)$1.3 B(+8%)
Share Price (Jun 2021)$21.5(-2%)
Cybersecurity ratingBMore

Key People/Management at R1 RCM

Joseph Flanagan

Joseph Flanagan

President & CEO
Rachel Wilson

Rachel Wilson

EVP, CFO & Treasurer
John Sparby

John Sparby

EVP, Chief Operating Officer
Julia Davis

Julia Davis

EVP, Chief Information Officer
Sean Radcliffe

Sean Radcliffe

EVP, General Counsel
Vijay Kotte

Vijay Kotte

EVP, Chief Solutions Officer
Show more

R1 RCM Office Locations

R1 RCM has offices in Chicago, Gurugram, Hyderabad and Noida
Chicago, IL, US (HQ)
Equitable Building, 401 N Michigan Ave Suite 630-640
Gurugram, IN
Tower No-1, Candor Tech Space, Sector 48
Hyderabad, IN
Survey No- 1, Plot, No. 6, Uppal - Ramanthapur Rd, Uppal
Noida, IN
Plot No 20, 21, Noida-Greater Noida Expy, Sector 135
Show all (4)

R1 RCM Financials and Metrics

R1 RCM Revenue

Embed Graph
View revenue for all periods
R1 RCM's revenue was reported to be $1.27 b in FY, 2020
USD

Revenue (Q1, 2021)

342.6m

Gross profit (Q1, 2021)

75.4m

Gross profit margin (Q1, 2021), %

22%

Net income (Q1, 2021)

25.8m

EBIT (Q1, 2021)

36.8m

Market capitalization (18-Jun-2021)

5.6b

Closing stock price (18-Jun-2021)

21.5

Cash (31-Mar-2021)

103.5m

EV

6.1b
R1 RCM's current market capitalization is $5.6 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

449.8m868.5m1.2b1.3b

Revenue growth, %

93%37%

Cost of goods sold

416.3m770.6m987.8m1.0b

Gross profit

33.5m97.9m198.3m249.7m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

86.9m99.4m123.2m147.3m207.9m250.4m275.9m295.0m301.2m320.5m314.7m307.2m342.6m

Cost of goods sold

80.9m96.4m111.8m138.7m189.9m219.3m237.2m246.1m241.9m253.9m248.3m255.2m267.2m

Gross profit

6.0m3.0m11.4m8.6m18.0m31.1m38.7m48.9m59.3m66.6m66.4m52.0m75.4m

Gross profit Margin, %

7%3%9%6%9%12%14%17%20%21%21%17%22%
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

164.9m62.8m92.0m173.8m

Accounts Receivable

8.2m42.2m52.3m91.3m

Prepaid Expenses

13.2m34.8m41.6m59.4m

Current Assets

202.3m196.8m216.7m355.4m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(58.8m)(45.3m)12.0m117.1m

Depreciation and Amortization

16.3m38.8m55.7m68.7m

Accounts Payable

(300.0k)(3.0m)9.9m(3.4m)

Cash From Operating Activities

20.9m18.3m113.9m61.8m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

(8.3m)(15.0m)(18.6m)(23.3m)(26.2m)(39.6m)200.0k(5.0m)4.2m18.2m33.3m38.5m25.8m

Depreciation and Amortization

3.2m7.0m11.5m4.9m13.4m27.6m12.9m25.8m39.9m15.7m33.6m50.9m22.3m

Accounts Payable

(4.0m)(2.3m)300.0k(1.4m)1.4m(6.0m)3.0m7.2m10.5m2.8m4.5m1.9m5.2m

Cash From Operating Activities

(27.9m)(22.9m)(4.3m)(9.9m)(21.1m)(6.0m)71.1m44.0m43.3m600.0k45.3m50.5m
USDQ1, 2017

Revenue/Employee

14.2k

Financial Leverage

3.8 x
Show all financial metrics

R1 RCM Operating Metrics

FY, 2019Apr, 2020Feb, 2021

New Net Patient Revenue under Management

$4.1 b

Clients

750900

Providers

27 k27 k

Patient Engagements per Year

30 m30 m
Show all operating metrics

R1 RCM Acquisitions / Subsidiaries

Company NameDateDeal Size
Cerner RevWorksAugust 03, 2020
SCI SolutionsApril 01, 2020$190 m
IntermedixMay 08, 2018$460 m
Accretive Health Mauritius, Inc.
Advanced Data Processing, Inc.
Intermedix Analytics, LLC
Intermedix ARM, LLC
Intermedix Corporation
Intermedix Holdings, Inc.
Intermedix Lietuva, UAB
Show more

R1 RCM Revenue Breakdown

Embed Graph

R1 RCM revenue breakdown by business segment: 87.5% from Net Operating Fees and 12.5% from Other

R1 RCM Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

R1 RCM Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

R1 RCM Online and Social Media Presence

Embed Graph

R1 RCM News and Updates

R1 RCM Announces Pricing of Secondary Offering of 15,000,000 Shares by Selling Stockholders

CHICAGO, May 26, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1 RCM” or the “Company”) (NASDAQ: RCM) announced that it has priced the underwritten offering of 15,000,000 shares of its common stock by selling stockholders at a price to the public of $22.50 per share. The selling stockholders are TCP-ASC…

R1 RCM Announces Commencement of Secondary Offering by Selling Stockholders

CHICAGO, May 25, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1 RCM” or the “Company”) (NASDAQ: RCM) announced the commencement of an underwritten offering of an aggregate of 15,000,000 shares of its common stock by selling stockholders. The selling stockholders are TCP-ASC ACHI Series LLLP (“TCP-ASC”)…

R1 RCM Reports First Quarter 2021 Results

CHICAGO, May 04, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended March 31, 2021.

R1 RCM to Release First Quarter 2021 Results on May 4

CHICAGO, April 20, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March…

R1 RCM to Present at the KeyBanc Life Sciences & MedTech Investor Forum

CHICAGO, March 09, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the KeyBanc Life Sciences & MedT…

R1 RCM Reports Fourth Quarter and Full Year 2020 Results

CHICAGO, Feb. 18, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2020.
Show more

R1 RCM Blogs

3 Ways Revenue Cycle Partnerships Produce Financial Sustainability

This post is part two of a two-part blog.   There is no doubt that many practices are in a strenuous financial period. Organizations need to quickly identify opportunities to reduce costs and increase profitability, which is making them seriously consider outsourcing their revenue cycl…

Why CBOs Aren't Financially Viable for Practices

This post is part one of a two-part blog.   It’s no secret that over the past few years, physician organizations have faced several significant financial hurdles. From adjusting to value-based care, to serving more and more underinsured patients, to the most recent financial hit: deali…

For the Record: A Look Inside Intelligent Automation

Over the past five years, there has been significant buzz in the health care industry around automation, including countless articles advertising how it can transform the revenue cycle while delivering major cost savings. For the most part, the fanfare is warranted; automation can help g…

HealthLeaders: Price Transparency is Here, Actions to Take

The CMS price transparency mandate is in effect at long last, after a yearlong delay, court challenges, worries over confused patients, concerns about disclosing proprietary data, and COVID-19-related setbacks.

RAC Monitor: Leaving Against Medical Advice

Against Medical Advice: Are A M A Scarlet Letters?A recent discussion on Twitter caught my attention. A physician posted, “Left against medical advice” is not the same as ‘Left to attend sister’s funeral.’ Let’s choose our words better.” This doctor has a point. The choice of words we us…

Hospital readmissions: Stay compliant and provide the best care

Hospitals may want to reconsider how hard they work to stave off certain Medicare readmissions because the penalties from the Hospital Readmissions Reduction Program pale compared to the loss of revenue and potential harm to patients who should be back in the hospital, a physician adviso…
Show more

R1 RCM Frequently Asked Questions

  • When was R1 RCM founded?

    R1 RCM was founded in 2003.

  • Who are R1 RCM key executives?

    R1 RCM's key executives are Joseph Flanagan, Rachel Wilson and John Sparby.

  • How many employees does R1 RCM have?

    R1 RCM has 19,000 employees.

  • What is R1 RCM revenue?

    Latest R1 RCM annual revenue is $1.3 b.

  • What is R1 RCM revenue per employee?

    Latest R1 RCM revenue per employee is $66.9 k.

  • Who are R1 RCM competitors?

    Competitors of R1 RCM include NextGen Healthcare, athenahealth and Allscripts.

  • Where is R1 RCM headquarters?

    R1 RCM headquarters is located at Equitable Building, 401 N Michigan Ave Suite 630-640, Chicago.

  • Where are R1 RCM offices?

    R1 RCM has offices in Chicago, Gurugram, Hyderabad and Noida.

  • How many offices does R1 RCM have?

    R1 RCM has 4 offices.